Table 2.

Hepatic and splenic metabolic activities (MRglu; μmol/min/100 ml), blood glucose concentration (mmol/l), hepatic and splenic CT densities (CTD; HU) and gender (male/female) in relation to recent chemotherapy (n = 43)

	MRglu		Glucose	CTD		Gender
	Liver	Spleen		Liver	Spleen	M/F
Recent chemotherapy (within 6 months of PET/CT)
Yes (n = 10)	2.1 (1.4)	2.3 (0.9)	5.7 (0.6)	45 (11)	41 (6)	8/2
No (n = 33)	2.1 (1.2)	3.1 (1.9)	5.8 (0.7)	47 (9)	38 (7)	25/8
p	>0.2	= 0.2	>0.2	>0.2	>0.2	>0.2